.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
AstraZeneca
Mallinckrodt
Covington
Cantor Fitzgerald
Merck
US Department of Justice
Deloitte
Novartis
Argus Health

Generated: September 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022029

« Back to Dashboard
NDA 022029 describes SALONPAS, which is a drug marketed by Hisamitsu Pharm Co and is included in one NDA. It is available from one supplier. There are two patents protecting this drug. Additional details are available on the SALONPAS profile page.

The generic ingredient in SALONPAS is menthol; methyl salicylate. There are seventeen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the menthol; methyl salicylate profile page.

Summary for NDA: 022029

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:2
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 022029

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SALONPAS
menthol; methyl salicylate
PATCH;TOPICAL 022029 NDA Hisamitsu Pharmaceutical Co., Inc. 46581-670 46581-670-01 1 PATCH in 1 POUCH (46581-670-01)
SALONPAS
menthol; methyl salicylate
PATCH;TOPICAL 022029 NDA Hisamitsu Pharmaceutical Co., Inc. 46581-670 46581-670-03 3 PATCH in 1 POUCH (46581-670-03)

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:PATCH;TOPICALStrength3%;10%
Approval Date:Feb 20, 2008TE:RLD:Yes
Patent:► SubscribePatent Expiration:Jan 3, 2030Product Flag?YSubstance Flag?Delist Request?
Patent:► SubscribePatent Expiration:Aug 1, 2027Product Flag?YSubstance Flag?Delist Request?

Summary for product number 002

Active Rx/OTC/Discontinued:OTCDosage:PATCH;TOPICALStrength3%;10%
Approval Date:Nov 5, 2012TE:RLD:Yes
Patent:► SubscribePatent Expiration:Jan 3, 2030Product Flag?YSubstance Flag?Delist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Chinese Patent Office
Citi
US Army
Express Scripts
Colorcon
UBS
Boehringer Ingelheim
Deloitte
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot